Icosavax focuses on computationally designed VLP vaccine development to reduce serious infectious diseases, including RSV.
Company (Alive / Active)
Phone:
1616 Eastlake Avenue E.
Suite 300
Seattle, 98102
Washington, United States
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|